Winton Matthew 4
4 · Inozyme Pharma, Inc. · Filed Apr 2, 2025
Insider Transaction Report
Form 4
Transactions
- Award
Common Stock
2025-03-31$0.77/sh+2,490$1,917→ 7,388 total
Footnotes (1)
- [F1]Shares purchased pursuant to the Inozyme Pharma, Inc. 2020 Employee Stock Purchase Plan ("ESPP"), for the ESPP purchase period of October 1, 2024 through March 31, 2025. In accordance with the ESPP, these shares were purchased at a price equal to 85% of the closing price of the Issuer's common stock on March 31, 2025, the last trading day of the purchase period.